Altre lingue Bausch Health Companies Inc.

Azioni

BHC

CA0717341071

Mercato chiuso - Nyse Altri mercati azionari 22:00:01 24/04/2024			Variaz. 5gg	Var. 1 gen.
8,56 ^USD	+0,35%		-1,15%	+6,73%

23/04	Bausch Health in 'posizione più forte' per la distribuzione di Bausch + Lomb, dice RBC	MT
23/04	RBC prevede il Q1 di Bausch Health, riducendo l'obiettivo a 11 dollari.	MT

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Bausch Health in 'Stronger Position' for Bausch + Lomb Distribution, RBC Says	23/04
RBC Previews Bausch Health's Q1, Trims Target to US$11	23/04
RBC Cuts Bausch + Lomb Target to US$18, Reiterates Outperform, as Previews Q1	22/04
Bausch Health's Issuer Credit Rating Upgraded by S&P	19/04
Bausch Health Gets 'Positive' Court Ruling on Xifaxan With Market Odds of Bausch + Lomb Distribution at 32%, RBC Says	12/04
RBC Notes "Positive" Appellate Court Ruling For Bausch Health, But Thinks Market Assigning ~32% BLCO Distribution Odds	12/04
Bausch Health, Canada Inc. - Acne vulgaris treatment PrARAZLO now available to patients through British Columbia PharmaCare public drug plan	12/04
Bausch Health Companies - Court of Appeals for the Federal Circuit Issues Ruling in Norwich Case that Prevents FDA Approval of Norwich's Abbreviated New Drug Application Until 2029	12/04
Bausch Health to Announce First-Quarter 2024 Results on May 2	12/04
Bausch wins US appeal to block Alvogen generic of diarrhea drug	11/04
Canadian Investment Regulatory Organization Trade Resumption - BHC	11/04
Canadian Investment Regulatory Organization Trading Halt - BHC	11/04
Bausch Health, Canada Inc. Announces Acne Vulgaris Treatment PrARAZLO(TM) (Tazarotene Lotion, 0.045%) Now Available to Patients Through British Columbia PharmaCare Public Drug Plan	11/04
TSX ends flat as gold stocks drop, mood cautious ahead of rate decision	08/04
Bausch Health Up Near 0.4% In US Premarket After Announcing Patent Lawsuit Against Amneal Pharmaceuticals	08/04
North American Morning Briefing : Inflation Data, -2-	08/04
Trump eyes $43 million haul from biggest fundraiser yet	06/04
RBC Raises Bausch Health Target to US$12, Maintains Sector Perform, on Upcoming Xifaxan Litigation Ruling	05/04
/C O R R E C T I O N from Source -- Canadian Investment Regulatory Organization (CIRO) - Halts/Resumptions/	03/04
Canadian Investment Regulatory Organization Trade Resumption - BHC	03/04

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Bausch Health Companies Inc.

Azioni

BHC

CA0717341071

Altre lingue

Filtri